These studies confirm the beneficial effects of GLP-1 receptor agonists on glucose, insulin and lipid metabolism [29,30], and others also demonstrate their efficacy on hepatic parameters including plasma ALT, total liver volume and hepatic steatosis [13,14]. The gene discussed is INS; the disease is Hepatic steatosis.